Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Benoit, Daneault"'
Publikováno v:
CJC Open, Vol 6, Iss 4, Pp 632-638 (2024)
Background: Primary percutaneous coronary intervention (PPCI) and fibrinolysis have proved to be major discoveries regarding treatment of ST-segment elevation myocardial infarction (STEMI). The threshold at which PPCI becomes less favourable than fib
Externí odkaz:
https://doaj.org/article/80c916952d3f4022947ff97a5bb706c1
Autor:
Laurie-Anne Boivin-Proulx, MD, MSc, Fabrice Ieroncig, MD, Simon-Pierre Demers, MD, Anna Nozza, MSc, Marwa Soltani, MD, Ismahane Ghersi, MD, Louis Verreault-Julien, MD, Yahya Alansari, MD, Charles Massie, MD, Philippe Simard, MD, Lorena Rosca, MD, Jean-Simon Lalancette, MD, Gabriel Massicotte, MD, Annabel Chen-Tournoux, MD, Benoit Daneault, MD, Jean-Michel Paradis, MD, Jean G. Diodati, MD, Nicolas Pranno, MD, Marc Jolicoeur, MD, Brian J. Potter, MDCM, SM, Guillaume Marquis-Gravel, MD, MSc, Christine Pacheco, MD, MSc
Publikováno v:
CJC Open, Vol 6, Iss 2, Pp 362-369 (2024)
Background: In patients with anterior ST-elevation myocardial infarction (STEMI) and new-onset antero-apical wall motion abnormalities (WMAs), whether the rate of prophylaxis against left ventricular thrombus and outcomes differ between men and women
Externí odkaz:
https://doaj.org/article/6b7fb3601648432ab24a26bb8b945fb6
Autor:
Lena Rivard, MD, MSc, Isabelle Nault, MD, Andrew D. Krahn, MD, Benoit Daneault, MD, Jean-Francois Roux, MD, Madhu Natarajan, MD, Jeffrey S. Healey, MD, MSc, Kenneth Quadros, MD, Roopinder K. Sandhu, MD, MPH, Remi Kouz, MD, Isabelle Greiss, MD, Peter Leong-Sit, MD, Jean Baptiste Gourraud, MD, Walid Ben Ali, MD, PhD, Anita Asgar, MD, Msc, Martin Aguilar, MD, PhD, Raoul Bonan, MD, Julia Cadrin-Tourigny, MD, PhD, Raymond Cartier, MD, Jean-Francois Dorval, MD, Marc Dubuc, MD, Nicolas Dürrleman, MD, MSc, Katia Dyrda, MD, Peter Guerra, MD, Marina Ibrahim, MD, MSc, Reda Ibrahim, MD, Laurent Macle, MD, Blandine Mondesert, MD, Emmanuel Moss, MD, MSc, Alexandre Raymond-Paquin, MD, Denis Roy, MD, Rafik Tadros, MD, PhD, Bernard Thibault, MD, Mario Talajic, MD, Anna Nozza, MSc, Marie-Claude Guertin, PhD, Paul Khairy, MD, PhD
Publikováno v:
CJC Open, Vol 5, Iss 8, Pp 611-618 (2023)
Patients with new-onset left bundle branch block (LBBB) after transcatheter aortic valve implantation (TAVI) are at risk of developing delayed high-degree atrioventricular block. Management of new-onset LBBB post-TAVI remains controversial. In the Co
Externí odkaz:
https://doaj.org/article/383ceca970714c38b95cb0bb6d93659d
Autor:
Felipe H. Valle, MD, PhD, Shaun G. Goodman, MD, MSc, Mary Tan, MSc, Andrew Ha, MD, Samer Mansour, MD, Robert C. Welsh, MD, Andrew T. Yan, MD, Kevin R. Bainey, MD, MSc, Stephane Rinfret, MD, Brian J. Potter, MDCM SM, Razi Khan, MD, Gerald Simkus, MD, Madhu K. Natarajan, MD, J.D. Schwalm, MD, Benoit Daneault, MD, Mark J. Eisenberg, MD, MPH, Joseph Abunassar, MD, Bryan Har, MD, MPH, Jean Gregoire, MD, Jean-Francois Tanguay, MD, Christopher B. Overgaard, MD, Jean-Pierre Dery, MD, Robert De Larochelliere, MD, Jean-Michel Paradis, MD, Mina Madan, MD, MHS, Basem Elbarouni, MBBCh, Derek Y.F. So, MD, Ata-Ur-Rehman Quraishi, MBBS, Akshay Bagai, MD, MHS
Publikováno v:
CJC Open, Vol 3, Iss 12, Pp 1419-1427 (2021)
Background: In patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI), selecting an antithrombotic regimen requires balancing risks of ischemic cardiac events, stroke, and bleeding. Methods: We studied 467 patients
Externí odkaz:
https://doaj.org/article/eb37fce9ac584e069aa2601948f5239b
Autor:
Laurie-Anne Boivin-Proulx, Fabrice Ieroncig, Simon-Pierre Demers, Anna Nozza, Marwa Soltani, Ismahane Ghersi, Louis Verreault-Julien, Yahya Alansari, Charles Massie, Philippe Simard, Lorena Rosca, Jean-Simon Lalancette, Gabriel Massicotte, Annabel Chen-Tournoux, Benoit Daneault, Jean-Michel Paradis, Jean G. Diodati, Nicolas Pranno, Marc Jolicoeur, Brian J. Potter, Guillaume Marquis-Gravel
Publikováno v:
Clinical Research in Cardiology. 112:558-565
Autor:
Philippe Généreux, Gil Chernin, Abid R. Assali, Jan Z. Peruga, Simon D. Robinson, Erick Schampaert, Rodrigo Bagur, Samer Mansour, Josep Rodés-Cabau, Margaret McEntegart, Robert Gerber, Philippe L'Allier, Ranil de Silva, Benoit Daneault, Suneil K. Aggarwal, Vladimír Džavík, M. Ozgu Ozan, Ori Ben-Yehuda, Akiko Maehara, Gregg W. Stone, Michael Jonas
Publikováno v:
American Heart Journal. 249:45-56
Diabetes mellitus (DM) is an important predictor of neointimal hyperplasia (NIH) and adverse clinical outcomes after percutaneous coronary intervention (PCI). LABR-312, a novel intravenous formulation of liposomal alendronate, has been shown in anima
Publikováno v:
Canadian Journal of Cardiology.
Autor:
Shaun G. Goodman, Gerald Simkus, Mark J. Eisenberg, Mina Madan, Akshay Bagai, Jean-François Tanguay, Samer Mansour, Felipe H. Valle, Andrew T. Yan, Benoit Daneault, Jean Grégoire, Derek So, Christopher B. Overgaard, Jean-Michel Paradis, Stéphane Rinfret, Kevin R. Bainey, Jean-Pierre Déry, Mary Tan, B. Har, Razi Khan, Basem Elbarouni, Robert C. Welsh, Ata-Ur-Rehman Quraishi, J. Schwalm, Robert De Larochellière, Madhu K. Natarajan, Andrew C.T. Ha, Brian J. Potter, Joseph Abunassar
Publikováno v:
CJC Open
CJC Open, Vol 3, Iss 12, Pp 1419-1427 (2021)
CJC Open, Vol 3, Iss 12, Pp 1419-1427 (2021)
Background: In patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI), selecting an antithrombotic regimen requires balancing risks of ischemic cardiac events, stroke, and bleeding. Methods: We studied 467 patients
Autor:
Laurie-Anne, Boivin-Proulx, Simon-Pierre, Demers, Fabrice, Ieroncig, Anna, Nozza, Marwa, Soltani, Yahya, Alansari, Charles, Massie, Philippe, Simard, Lorena, Rosca, Ismahane, Ghersi, Louis, Verreault-Julien, Jean-Simon, Lalancette, Gabriel, Massicotte, Annabel, Chen-Tournoux, Benoit, Daneault, Jean-Michel, Paradis, Jean G, Diodati, Nicolas, Pranno, Marc, Jolicoeur, Brian J, Potter, Guillaume, Marquis-Gravel
Publikováno v:
The Journal of invasive cardiology. 34(12)
The objective is to assess the comparative effectiveness and safety of dual-antiplatelet therapy (DAPT) vs triple therapy (TT) with DAPT + oral anticoagulant (OAC) in patients with anterior ST-segment elevation myocardial infarction (STEMI) and with
Autor:
Jeffrey L. Carson, Maria Mori Brooks, Bernard R. Chaitman, John H. Alexander, Shaun G. Goodman, Marnie Bertolet, J. Dawn Abbott, Howard A. Cooper, Sunil V. Rao, Darrell J. Triulzi, Dean A. Fergusson, William J. Kostis, Helaine Noveck, Tabassome Simon, Philippe Gabriel Steg, Andrew P. DeFilippis, Andrew M. Goldsweig, Renato D. Lopes, Harvey White, Caroline Alsweiler, Erin Morton, Paul C. Hébert, Shahab Ghafghazi, Frances Wood, Mark Menegus, Barry Uretsky, Srikanth Vallurupalli, Gregory Maniatis, Luis Gruberg, Robert Roswell, Joseph Rossi, Farhad Abtahian, Meechai Tessalee, Gregory Barsness, Herbert Aronow, Kodangudi Ramanathan, Mark Schmidhofer, Friederike Keating, Michael Carson, Michael Kontos, Mansoor Qureshi, Stacey Clegg, Warren Laskey, Tamar Polonsky, Rajesh Gupta, Mujeeb Abdul Sheikh, Lynne Uhl, Paul Mullen, Arthur Bracey, William Matthai, Christopher Stowell, David Dudzinski, Gregary Marhefka, Perry Weinstock, William Lawson, Norma Keller, Eugene Yuriditsky, Michael Thomas, Alice Jacobs, Claudia Hochberg, Omar Siddiqi, Joshua Schulman-Marcus, Mikhail Torosoff, Michael Gitter, Xuming Dai, Jay Traverse, Eric McCamant, Jason Scott, Rajesh Swaminathan, Sunil Rao, Adam Salisbury, David Landers, Ganesh Raveendran, Ramin Ebrahimi, Richard Bach, Joseph Delehanty, Raj C. Shah, Sorin Brener, Jonathan Doroshow, Adriano Caixeta, Dalton Precoma, Frederico Toledo Campo Dall'Orto, Pedro Beraldo De Andrade, Marianna Dracoulakis, Lília Nigro Maia, Luiz Eduardo Fontelles Ritt, Alexandre Quadros, Dário Celestino Sobral Filho, Fernando De Martino, Thao Huynh, Greg Schnell, Manohara Senaratne, Vikas Tandon, John Neary, David Laflamme, Jean-Pierre Dery, Kevin Bainey, Richard Haichin, Payam Dehghani, Ata Ur Rehman Quraishi, Brian J. Potter, François Martin Carrier, Michael Goldfarb, Christopher Fordyce, Ying Tung Sia, Benoit Daneault, Mina Madan, Terry McPherson, John Ducas, Kunal Minhas, Neil Brass, Akshay Bagai, Simon Robinson, Vladimír Džavík, Razi Khan, Nicolas Michaud, Gabriel Steg, Gregory Ducrocq, Etienne Puymirat, Gilles Lemesle, Emile Ferrari, Benoit Lattuca, Johanne Silvain, Gérald Vanzetto, Laura Cetran, Thibault Lhermusier, Yves Cottin, Yann Rosamel, Denis Angoulvant, Jean Guillaume Dillinger, Christophe Thuaire, Batric Popovic, Eric Durand, Claire Bouleti, François Roubille, Laurent Delorme, Ian Crozier, Jocelyne Benatar, Samraj Nandra, Ian Ternouth, Nick Fisher, David Brieger, Graham Hillis
Publikováno v:
American heart journal.
Accumulating evidence from clinical trials suggests that a lower (restrictive) hemoglobin threshold (8% g/dL) for red blood cell (RBC) transfusion, compared with a higher (liberal) threshold (≥10 g/dL) is safe. However, in anemic patients with acut